论文信息 - Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. - 字舞流文

Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.

T. Waldmann | M. Cerná | Roland Martin | H. McFarland | P. Henkart | B. Bielekova | Amy N. Packer | Susan A Reichert-Scrivner | M. Catálfamo | Susan A. Reichert-Scrivner